Rizatriptan is an antimigraine agent available under the brand names Maxalt-MLT®; Maxalt®. It is used in the treatment of acute treatment of migraine with or without aura.
| Reasons taken |
# of patients
Efficacy
|
Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Other | 1 |
|
1 | ||||
| Migraine Headaches | 1 | 0 | |||||
| Migraine | 1 |
|
1 |
See all 2 patients currently taking Rizatriptan
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Expense
|
1 | 100% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on March 16, 2010.